Trials / Sponsors / Leidos Life Sciences
Leidos Life Sciences
Industry · 4 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Completed | Vagal Approaches on Long COVID-19 Long COVID Symptoms | N/A | 2025-10-27 |
| Withdrawn | Leidos-Enabled Adaptive Protocol for Clinical Trials (LEAP-CT) in Hospitalized Patients With COVID-19 (Addendu 2019 Novel Coronavirus Disease, 2019 Novel Coronavirus Infection, 2019-nCoV Disease | Phase 2 | 2023-02-07 |
| Terminated | Leidos-Enabled Adaptive Protocol (LEAP-CT) for Evaluation of Post-exposure Prophylaxis for Newly-infected COVI 2019 Novel Coronavirus Disease, 2019 Novel Coronavirus Infection, 2019-nCoV Disease | Phase 2 | 2021-12-29 |
| Completed | LEAP-CT for Treatment of COVID-19 Patients (Master Protocol) 2019 Novel Coronavirus Disease, 2019 Novel Coronavirus Infection, 2019-nCoV Disease | Phase 2 | 2021-12-29 |